AEON Biopharma, Inc. (AEON)

US · Healthcare · Biotechnology

$0.25-4.28%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.2M

EPS

$-0.02

EPS estimate

$-0.33

EPS came in at -0.02 against a street estimate of -0.33 — a beat of 93.9%.

Market cap

$14.3M

Forward P/E

1.2

P/B

0.00

Book value

$-0.58

EPS (TTM)

$-4.55

52-week high

$1.45

52-week low

$0.18

50-day MA

$0.30

200-day MA

$0.80

Beta

0.65

Analysts rate AEON Biopharma, Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $1.52.

Insiders

53.47%

Institutions

32.75%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for AEON Biopharma, Inc. — free to start.

Data updated 2026-09-18.